Last Updated: September 24, 2026

Details for New Drug Application (NDA): 021758

✉ Email this page to a colleague

NDA 021758 describes VANOS, which is a drug marketed by Bausch and is included in one NDA. Additional details are available on the VANOS profile page.

The generic ingredient in VANOS is fluocinonide. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

Summary for 021758

Tradename:	VANOS
Applicant:	Bausch
Ingredient:	fluocinonide
Patents:	0

Medical Subject Heading (MeSH) Categories for 021758

Anti-Allergic Agents
Anti-Inflammatory Agents
Glucocorticoids

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	0.1%
Approval Date:	Feb 11, 2005	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021758

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	6,765,001	⤷ Start Trial
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	8,232,264	⤷ Start Trial
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	7,794,738	⤷ Start Trial
Bausch	VANOS	fluocinonide	CREAM;TOPICAL	021758-001	Feb 11, 2005	7,220,424	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.